Betrixaban 

贝曲沙班

Report date: 2022/01/21 20:00:34
NME

Base Information

Drug NameBetrixaban 
Drug Alias Name贝曲西班betrixabanumBevyxxaPRT-054021MLN-1021 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor Xa inhibitors
TargetsCoagulation factor X
Therapy Area/IndicationsVenous ThromboembolismThromboembolismAtrial Flutter +[6] 
Global Approved IndicationsVenous Thromboembolism
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2017/06/23
Country/TerritoryCzechiaBelgiumBulgaria +[35] 
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesMillennium Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPortola PharmaceuticalsAlexion Pharmaceuticals IncPortola Pharma Uk Ltd +[4] 
Active IndicationsN/A
Inactive IndicationsVenous ThromboembolismThromboembolismAtrial Flutter +[6] 

Other Information

ATC CodeB01AF
Related LinksWikipediaDrugBankKEGG